CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- 4 Option exercise See Remarks acquired 3,989 shares (option exercise)
- 4 Option exercise CEO acquired 7,979 shares (option exercise)
- 4 Option exercise See Remarks acquired 725 shares (option exercise)
- 4 Open-market sale See Remarks sold 564 shares at $17.06 ($9,623)
- 4/A Open-market sale See Remarks sold 1,076 shares at $19.06 ($20,509)
- 4 Option exercise See Remarks acquired 3,333 shares (option exercise)
- 4 Open-market sale Director sold 14,989 shares at an average $21.07 ($315,744)
- 4 Derivatives Options or other derivatives
- 4 Other disposition Director disposed of 1,000,000 shares (other)
- 4 Open-market sale See Remarks sold 1,534 shares at $15.47 ($23,733)
- 4 Open-market sale CEO sold 4,767 shares at $15.47 ($73,750)
- 4 Open-market sale See Remarks sold 284 shares at $15.47 ($4,394)
- 4 Option exercise See Remarks acquired 725 shares (option exercise)
- 4 Option exercise See Remarks acquired 3,989 shares (option exercise)
- 4 Option exercise CEO acquired 7,979 shares (option exercise)
- 4 Open-market sale See Remarks sold 573 shares at $19.03 ($10,906)
- 4 Option exercise See Remarks acquired 1,586 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 21 · 406 filings